Practical aspects of vaccination of poultry against avian influenza virus

- The approach to vaccination of poultry (chickens, turkeys and ducks) for avian influenza has evolved as highly pathogenic (HP) AIV has become endemic in several regions of the world.
- Vaccination for low pathogenicity (LP) AIV is also becoming routine in regions where there is a high field challenge.
- In contrast, some countries will not use vaccination at all and some will only use it on an emergency basis during eradication efforts (i.e. stamping-out).
- There are pros and cons to each approach and, since every outbreak situation is different, no one method will work equally well in all situations.
- Numerous practical aspects must be considered when developing an AIV control program with vaccination.
- The goals of vaccination must be defined.
- The population to be vaccinated must be clearly identified.
- There must be a plan to obtain and administer good quality vaccine in a timely manner and to obtain adequate coverage with the available resources.
- Risk factors for vaccine failure should be mitigated as much as possible.
- Biosecurity must be maintained as much as possible, if not enhanced during the vaccination period.

Although little has changed in vaccine technology for avian influenza virus (AIV) in the past 20 years, the approach to vaccination of poultry (chickens, turkeys and ducks) for avian influenza has evolved as highly pathogenic AIV has become endemic in several regions of the world. Vaccination for low pathogenicity AIV is also becoming routine in regions where there is a high level of field challenge. In contrast, some countries will not use vaccination at all and some will only use it on an emergency basis during eradication efforts (i.e. stamping-out). There are pros and cons to each approach and, since every outbreak situation is different, no one method will work equally well in all situations. Numerous practical aspects must be considered when developing an AIV control program with vaccination as a component, such as: (1) the goals of vaccination must be defined; (2) the population to be vaccinated must be clearly identified; (3) there must be a plan to obtain and administer good quality vaccine in a timely manner and to achieve adequate coverage with the available resources; (4) risk factors for vaccine failure should be mitigated as much as possible; and, most importantly, (5) biosecurity must be maintained as much as possible, if not enhanced, during the vaccination period.